First Fiduciary Investment Counsel Inc. Decreases Stake in Oracle Corporation $ORCL

First Fiduciary Investment Counsel Inc. cut its stake in shares of Oracle Corporation (NYSE:ORCL) by 29.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,203 shares of the enterprise software provider’s stock after selling 21,454 shares during the period. Oracle comprises approximately 2.9% of First Fiduciary Investment Counsel Inc.’s investment portfolio, making the stock its 9th biggest position. First Fiduciary Investment Counsel Inc.’s holdings in Oracle were worth $14,682,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Winnow Wealth LLC acquired a new stake in Oracle in the second quarter valued at $28,000. Kilter Group LLC bought a new stake in shares of Oracle in the 2nd quarter valued at about $30,000. Darwin Wealth Management LLC grew its position in shares of Oracle by 130.0% in the 3rd quarter. Darwin Wealth Management LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after buying an additional 65 shares during the last quarter. LGT Financial Advisors LLC acquired a new stake in shares of Oracle in the second quarter valued at about $33,000. Finally, Financial Consulate Inc. bought a new position in shares of Oracle during the third quarter worth about $37,000. Institutional investors and hedge funds own 42.44% of the company’s stock.

Insider Buying and Selling

In other news, CEO Clayton M. Magouyrk sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $192.52, for a total value of $1,925,200.00. Following the transaction, the chief executive officer owned 144,030 shares in the company, valued at $27,728,655.60. This trade represents a 6.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Douglas A. Kehring sold 35,000 shares of Oracle stock in a transaction that occurred on Thursday, January 15th. The shares were sold at an average price of $194.89, for a total value of $6,821,150.00. Following the transaction, the executive vice president directly owned 33,638 shares in the company, valued at approximately $6,555,709.82. The trade was a 50.99% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 62,223 shares of company stock valued at $12,136,764. 40.90% of the stock is owned by company insiders.

Oracle Stock Performance

NYSE ORCL opened at $146.75 on Thursday. The company has a market cap of $421.63 billion, a P/E ratio of 27.58, a PEG ratio of 1.35 and a beta of 1.64. The company has a fifty day simple moving average of $191.31 and a 200 day simple moving average of $235.52. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72.

Oracle (NYSE:ORCL) last released its quarterly earnings data on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.62. The firm had revenue of $16.06 billion for the quarter, compared to analyst estimates of $16.19 billion. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period last year, the firm earned $1.47 earnings per share. Sell-side analysts predict that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 23rd. Shareholders of record on Friday, January 9th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Friday, January 9th. Oracle’s payout ratio is currently 37.59%.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle Health won a multi-organization pilot in Canada for its Clinical AI Agent, validating commercial traction for Oracle’s healthcare AI products. Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent
• Positive Sentiment: Oracle’s recent $25B bond offering reportedly attracted heavy demand, indicating strong investor appetite for its debt and suggesting financing channels are open. Oracle Stock (ORCL) Gains as $25B Bond Offering Attracts Heavy Demand
• Positive Sentiment: Some sell-side firms (e.g., Barclays) have reiterated bullish ratings and high price targets, implying analysts still see upside if Oracle executes its AI/data-center strategy. Barclays Reiterates Overweight on Oracle
• Neutral Sentiment: Oracle announced an equity distribution agreement and senior notes issuance to fund its plans — this provides capital but increases near-term financing activity and complexity. Oracle Bolsters Financing with Major Senior Notes Issuance
• Neutral Sentiment: Oracle continues product and go-to-market pushes (AI banking platform, enterprise AI agents) that could drive long-term growth but require heavy near-term capex. Oracle Reimagines Banking for the AI Era
• Neutral Sentiment: Strategic commentary ties Oracle’s massive data-center and power plans to a structural shift (e.g., MarketBeat piece on companies funding power and SMRs); long-term strategic rationale exists but is execution- and timeline-dependent. The Atomic Pivot: AI’s $50 Billion Power Move
• Negative Sentiment: Markets punished Oracle after management outlined plans to raise roughly $45–50B for AI infrastructure (debt and equity), stoking dilution and leverage fears and sparking the recent sell-off. Oracle (ORCL) Is Down 11.6% After Unveiling a US$45–50 Billion AI Infrastructure Capital Plan
• Negative Sentiment: Multiple law firms have filed or are soliciting clients for securities class actions tied to Oracle’s disclosures (senior notes/offering documents and the June–Dec 2025 class period), adding legal risk and headline pressure. Kessler Topaz Files Securities Fraud Class Action Against Oracle
• Negative Sentiment: Reports say banks are exploring selling billions in loans tied to Oracle’s data centers and the company may cut up to 30,000 jobs — both raise execution and integration risks and amplify downside sentiment. Oracle Stock (ORCL) Slips as Banks Explore Selling Its Data Center Loans Oracle May Slash Up to 30,000 Jobs
• Negative Sentiment: Analysts have trimmed price targets (BMO, Scotiabank among them) and commentary highlights investor anxiety about the size/timing of the capital raise and AI execution — contributing to the stock’s decline. Oracle Price Target Lowered at BMO

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Piper Sandler reduced their price objective on shares of Oracle from $290.00 to $240.00 and set an “overweight” rating on the stock in a research note on Monday. Oppenheimer reiterated a “market perform” rating on shares of Oracle in a report on Thursday, December 11th. Mizuho set a $400.00 price objective on Oracle in a research note on Monday, December 15th. Stifel Nicolaus decreased their target price on Oracle from $350.00 to $275.00 and set a “buy” rating for the company in a research note on Thursday, December 11th. Finally, Weiss Ratings downgraded Oracle from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, January 23rd. Three research analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Oracle has an average rating of “Moderate Buy” and an average target price of $296.03.

Oracle Company Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.